The pelacarsen Phase 3 trial failed to reduce major cardiovascular events despite substantially lowering lipoprotein(a) levels, Novartis said.
Browsing: Markets
The FDA Etcamah approval covers an AstraZeneca combination for ESR1-mutated advanced breast cancer and authorizes Guardant360 CDx as its…
An Anthropic IPO report says Morgan Stanley and Goldman Sachs are close to securing senior roles, but the private AI company has not confirmed the…
The USA Rare Earth securities shelf would allow the company to offer up to $1.25 billion of stock, debt and other instruments over time.
Samsara revenue growth reached 30% in the fiscal second quarter, while annual recurring revenue climbed to $2.125 billion and the company remained…
The Lululemon earnings outlook was reduced after second-quarter revenue fell 4%, comparable sales declined 9% and operating income dropped 13%.
The Adobe CEO transition will place Anil Chakravarthy in charge on December 1, while longtime chief Shantanu Narayen becomes executive chair.
The VantageScore mortgage expansion allows all lenders originating Fannie Mae and Freddie Mac loans to use the 4.0 model effective immediately.
The Tesla Cybercab launch is moving from an invitation-only event to public rides in Austin as the purpose-built autonomous vehicle joins Robotaxi…
The FCC has reportedly asked a federal court to dismiss Disney’s challenge to an accelerated review of eight ABC television station licenses.